(19)
(11) EP 1 309 617 A2

(12)

(88) Date of publication A3:
13.03.2003

(43) Date of publication:
14.05.2003 Bulletin 2003/20

(21) Application number: 01956723.9

(22) Date of filing: 09.07.2001
(51) International Patent Classification (IPC)7: C07K 14/16, C12N 7/00, C12N 7/02
(86) International application number:
PCT/IB0101/208
(87) International publication number:
WO 0200/4494 (17.01.2002 Gazette 2002/03)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 07.07.2000 US 216995 P
10.07.2000 ZA 200003437
15.09.2000 ZA 200004924

(71) Applicants:
  • MEDICAL RESEARCH COUNCIL
    7500 Cape Town (ZA)
  • University of Cape Town
    7500 Cape Town (ZA)
  • THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
    Chapel Hill, NC 27599-4100 (US)
  • Alphavax, Inc.
    Research Triangle Park, NC 27709-0307 (US)

(72) Inventors:
  • WILLIAMSON, Carolyn
    7500 Cape Town (ZA)
  • SWANSTROM, Ronald, Ivar
    Chapel Hill, NC 27599-4100 (US)
  • MORRIS, Lynn
    2131 Sandringham (ZA)
  • KARIM, Salim, Abdool
    7500 Cape Town (ZA)
  • JOHNSTON, Robert, Edward
    Chapel Hill,NC 27599-410 0 (US)

(74) Representative: Jones, Elizabeth Louise 
Frank B. Dehn & Co.,179 Queen Victoria Street
London EC4V 4EL
London EC4V 4EL (GB)

   


(54) PROCESS FOR THE SELECTION OF HIV-1 SUBTYPE C ISOLATES, SELECTED HIV-1 SUBTYPE ISOLATES, THEIR GENES AND MODIFICATIONS AND DERIVATIVES THEREOF